Drug details

Carimune (immune globulin intravenous (human) nanofiltered lyophilized preparation)

type of Immune Globulins

Carimune NF, Nanofiltered, Immune Globulin Intravenous (Human), is an antibody product indicated for the maintenance treatment of patients with primary immunodeficiencies (PID), e.g., common variable immunodeficiency, X-linked agammaglobulinemia, severe combined immunodeficiency. Carimune NF is preferable to intramuscular Immune Globulin (Human) preparations in treating patients who require an immediate and large increase in the intravascular immunoglobulin level, in patients with limited muscle mass, and in patients with bleeding tendencies for whom intramuscular injections are contraindicated.

This drug may have the following side effects:
  • nausea
  • fever
  • sweating
  • dizziness
  • chills
  • muscle pain
  • joint pain
  • flushing of the face
  • feelings of tightness in the chest
  • low or high blood pressure (hypotension or hypertension)
  • temporary skin reactions (rash, swelling, itching, hives, eczema, or dermatitis)
The following drugs are related to Carimune, either as a replacement or used together:
  • Baygam (immune globulin)
  • Bivigam (immune globulin intravenous (human), 10%)
  • Flebogamma (immune globulin (human) intravenous solution)
  • Gammagard (immune globulin)
  • Gammagard Liquid (immune globulin intravenous (human) 10%)
  • Gamunex (immune globulin intravenous (human) 10%)
  • Gamunex-C (immune globulin injection (human) 10% caprylate/chromatography purified])
  • Privigen (immune globulin intravenous)
  • Octagam (immune globulin intravenous (human) 5% liquid preparation)
  • Panzyga (immune globulin intravenous, human - ifas liquid preparation)
  • Xembify (immune globulin subcutaneous, human – klhw injection)